Elevated levels of linoleoyl-L-carnitine (chloride) (CAR18:2; C18:2 carnitine) in the liver have been observed in mice treated with high-dose isoniazid, suggesting its potential use as a biomarker for isoniazid-induced metabolic alterations or hepatotoxicity.